Viral Infections in Heme Disorders Flashcards

1
Q

viral infections - general principles

A

viruses…
*are obligate intracellular organisms
*utilize host cell machinery to replicate
*often exhibit tropism for specific cell type(s)
*may establish latency/chronic infection as part of the natural history of infection w/ potential for reactivation
*are often difficult to diagnose
*are challenging to treat because therapeutic windows are typically narrow and available antiviral therapies are limited in number

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

infectious mononucleosis syndrome - clinical features

A

*malaise/fatigue
*fever
*sore throat w/ or w/o exudative pharyngitis
*hepatosplenomegaly
*absolute mononuclear cell predominance with the presence of “atypical” lymphocytes
*anemia and/or thrombocytopenia
*transaminitis with ALT>AST; total bili may also be increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ddx of infectious mononucleosis syndrome

A

*EBV
*CMV
*HIV
*toxoplasmosis
*HHV-6
*group A strep
*viral hepatitis
*lymphoma or other lymphoproliferative disorders
*drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

viral ddx of (pan)cytopenias in immunoCOMPETENT host

A

*parvovirus B19
*EBV
*CMV
*HIV
*HBV/HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

parvovirus B19 - overview

A

*single strand DNA virus which exclusively infects humans
*transmission via respiratory route
*exposure to virus is common & generally occurs early in life
*infection targets ERYTHROID PROGENITORS which leads to cessation of RBC production:
-transient in the normal host
-prolonged and severe in pts with baseline increased erythropoiesis (ex. sickle cell) or host immunocompromise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

parvovirus B19 - clinical manifestations

A

*erythema infectiousum (Fifth disease):
-healthy children
-febrile prodrome, then “slapped cheek” facial rash

*polyarthropathy syndrome:
-healthy adults
-symmetric arthritis that may mimic RA

*transient aplastic crisis (TAC)
*pure red cell aplasia/chronic anemia
*hydrops fetalis (pregnant women)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

parvovirus B19 - diagnosis

A

*IgM antibody in normal hosts or those with TAC
*parvovirus B19 virus DNA in immunocompromised hosts
*giant pronormoblasts (see image) on exam of bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

parvovirus B19 - management

A

*RBC transfusions as indicated
*intravenous immunoglobulin (IVIG) for ICHs
*no specific antiviral Rx available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Epstein-Barr Virus (EBV) - overview

A

*DNA virus in the family Herpesviridae
*worldwide in occurrence with peaks of infection in early childhood and late adolescence
*90% of adults are seropositive
*spread by contact with oral secretions
*primary infection involves epithelial cells of oropharynx & salivary glands -> B lymphocytes (which become “immortal”) -> lifetime latent infection with potential for reactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Epstein-Barr Virus (EBV) - associations with malignancy

A

*Burkitt lymphoma
*anaplastic nasopharyngeal carcinoma (southern China)
*Hodgkin disease
*non-hodgkin lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Epstein-Barr Virus (EBV) - diagnostic tools

A

*heterophile antibody (monospot test):
-Ab that agglutinates sheep, horse, or cow RBCs
-does not interact with EBV proteins
-about 80% sensitivity
-note: this is the FIRST test you would order

*specific EBV serologies:
-Abs to viral capsid antigen (VCA IgG and IgM)
-Abs to early antigens (EA-D and EA-R)
-Abs to Epstein-Barr nuclear antigen (EBNA)
-used for patients with suspected EBV who are heterophile neg or for pts with atypical infections

*PCR for EBV DNA in blood or tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Epstein-Barr Virus (EBV) - management

A

*supportive/symptomatic
*avoidance of strenuous activity

*glucocorticoids (in some cases):
-impending airway obstruction
-AIHA or severe thrombocytopenia
-CNS or cardiac complications
*no antiviral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cytomegalovirus (CMV) - overview

A

*double-stranded DNA virus in family Herpesviridae with potential for both lytic (productive) & latent infection
*worldwide distribution with most infection occurring perinatally & in early childhood
*transmission can occur by multiple routes (secretions, blood, breast milk, sexually) but often requires intimate or prolonged exposure
*infection may target multiple cells (WBCs, endothelium, epithelium, fibroblasts), often resulting in enlarged cells w/ intranuclear & cytoplasmic inclusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

cytomegalovirus (CMV) - clinical features (in immunocompetent host)

A

*asymptomatic infection
*congenital infection (usually associated with primary infection in mom; petechiae, HSM, jaundice)
*perinatal infection (often asymptomatic)
*CMV mononucleosis syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cytomegalovirus (CMV) - diagnosis

A

*clinical diagnosis not reliable
*serodiagnostic testing in serum? cell culture? PCR?

*HISTOPATHOLOGY of tissue:
-demonstration of virocytes (cytomegalic cells with inclusions -> “owl eyes”)
-immunohistochemical staining w/ monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

cytomegalovirus (CMV) - management

A

*symptomatic/supportive care usually sufficient
*for unusually severe disease, specific Rx w/ either ganciclovir or valganciclovir may be considered

17
Q

viral opportunistic infections in immunocompromised hosts - general concepts

A

*immune response to viral infection mediated by both antibody & cell-mediated immunity
*so, viral opportunistic infections most common and important in:
-pts receiving high dose steroids or other immunosuppressives
-pts with primary lymphoid or lymphocyte malignancies
-transplant patients
-HIV infection

18
Q

major causative pathogens of viral opportunistic infections in immunocompromised hosts

A
  1. common respiratory viruses (influenza, parainfluenza, RSV, hMPV, SARS-CoV-2)
  2. herpesviruses (HSV, VZV, HHV-6, CMV, EBV)
  3. other viruses (norovirus/rotavirus, HBV)
19
Q

what is the best way to make a diagnosis of a viral URI

A

PCR from nasopharyngeal swab

20
Q

cytomegalovirus (CMV) - clinical features (in immunocompromised host)

A

*primary infection (exposure, blood products, transplanted organ/tissues) vs reactivation
*manifestations include undifferentiated fever with viremia, pneumonitis, retinitis, hepatitis, GI disease, &/or CNS infection
*dx: PCR, tissue histopathology, antigen detection, viral culture
*Rx: ganciclovir, valganciclovir, foscarnet

21
Q

herpes zoster/VZV in immunocompromised hosts - overview

A

*primary infection = Varicella (chickenpox) whereas reactivation infection = Zoster (shingles)
*zoster may occur either after natural infection or after varicella vaccination
*risk increased with age

22
Q

herpes zoster/VZV in immunocompromised hosts - clinical manifestations

A

*painful dermatomal vesicular eruptions
*disseminated cutaneous disease
*pneumonitis
*hepatitis
*CNS infection

23
Q

herpes zoster/VZV in immunocompromised hosts - diagnosis

A

*PCR or culture of blood, skin lesions, or other fluids/tissues

24
Q

herpes zoster/VZV in immunocompromised hosts - treatment

A

*IV acyclovir or oral acyclovir, valacyclovir, or famciclovir

25
Q

herpes zoster/VZV in immunocompromised hosts - prevention

A

*recombinant (non-live) zoster vaccine (RZV)
*VZIG (immune globulin) in non-immune, recently exposed persons